Ovarian cancer chemotherapy

(1), ovarian cancer-chemotherapy drug commonly used drug <BR> melphalan (PAM) 0.2 ^ / ㎏ d, oral, 4 ~ for a course on the 5th, rest four to six weeks after duplication. Thiotepa (161-169) 10 ^ / times, intramuscular or intravenous injection, used five times, every other day to once a total of 300 ~ 500 days for an induction course. 6 to 8 weeks under the condition repeat. Cyclophosphamide (CTX) 50 ~ 100 ^ / day, oral, 7 ~ 10 Tianyi treatment, two weeks after duplication. Or 400 ^ / day, intravenous, oral to four days. Adriamycin (ADM) 50 ~ 70 ^ / ㎡, intravenous injection. Every three weeks.
(2), and malignant ovarian tumor joint chemical treatment of ovarian cancer chemotherapy are better response. In recent years the chemical treatment of tumors faster progress in the treatment of ovarian cancer Habitat has an important place to improve the treatment of ovarian cancer play a positive role as a surgical adjuvant therapy, commonly used in the preoperative, intraoperative and postoperative, but often require a longer period of intermittent medication, and the human body toxicity also sometimes larger. In most cases, it is difficult to ovarian cancer surgery primary tumor and metastasis consider chemical treatment based treatment.

Tags: body, cancer, cases, chemotherapy, days, drug, eat, injection, intravenous, malignant, metastasis, ovarian, positive, response, surgery, surgical, therapy, time, toxicity, treatment, tumor, tumors

Complications

Common complications of ovarian cancer tumor rupture, hemorrhage, secondary infection, anemia, cancer of the intestine cancer and intestinal infarction colic.

Tags: abdominal, age, anti, benign, body, breast, cancer, carcinoma, cases, cause, cell, chemotherapy, cyst, cystic, cysts, diagnosis, early, eat, examination, gene, grams, increased, malignant, mass, ovarian, pain, patients, pelvic, response, risk, second, surgery, symptoms, syndrome, tea, therapy, time, treatment, tumor, tumors, usually, uterine, women

The new treatment of cervical cancer vaccine vector - tobacco

Georgetown University Medical Center and the North Carolina State University researchers using tobacco to produce antibodies for the human papilloma (HPV) virus gene fragments. This project has been $ 3 million of government funding. Georgetown University study for Dr. Kencomh Dretchen said, because HPV is the main risk factors of cervical cancer, the objective of this study is to be against the virus antibodies.

He said, "I do not know what reasons, in normal circumstances HPV difficult to growth and development." Therefore, we extracted from the HPV genetic material transplanted to the tobacco virus to amplified fragment.

Tags: age, anti, cancer, cause, clinical, eat, gene, growth, hpv, mass, risk, study, treatment

Disseminated and ovarian cancer metastasis

Disseminated
and metastasis
1. Transfer of malignant
ovarian tumor growth and metastasis, and other parts of the same direct
spread of cancer, and the lymphatic and blood way. But the transfer spread
mainly by direct more directly transferred to pots, abdominal organs
and organizations, or transfer of Tai omentum, mesenteric, in a number
of intraperitoneal nodular mass, a certain degree of mobility; Peritoneal
or transferred to the pelvic floor in the vaginal fornix after palpation,
palpable in the womb may have rectal Waterloo a papillary protrusions,
even penetrating pelvic viscera, a sinus, and the rectum,; a vaginal
or urethral cancer tissue from the pus and bleeding. Ovarian cancer found
in the lymph node metastasis rate as high as 50%, or even transferred
to the left supraclavicular lymph nodes, or perineum, is in the diagnosis
and treatment of ovarian cancer, attention.
2.
Common vicious invasion on the side of the fixed pelvic advanced malignant
ovarian tumors, resulting in partial perivascular infiltration oppression,
to the side of lower extremity venous disruption, edema formation. If
the intestine of oppression by the vicious invasion, caused obstruction
symptoms; Ureteral pressure, often the hydronephrosis.
Phase
I clinical Asia ovarian cancer metastasis

Positions The number of cases Transfer rate (%)
Tags: abdominal, bleeding, blood, cancer, cases, cause, cell, cells, clinical, diagnosis, eat, ert, growth, intraperitoneal, lymph, malignant, mass, metastasis, node, oppression, ovarian, pelvic, rate, symptoms, treatment, tumor, tumors

Protect your health Ovarian

Xiaoya 35-year-old three years ago has just done a mother, early last year because of improper contraception and pregnancy. Finish abortion, xiaoya did not feel that their physical Breckenridge. But this summer she saw his terrible physical changes: the original sleek hair limbs suddenly developed, and even the lips of sorts-a lot to live in.. "I do not know that abortion is not the reason?" Xiaoya hearts quietly committed abroad, and has since skirts and Farewell.
Suddenly developed sweat glands finally explained. It is the company's first comprehensive medical examination, an experienced doctor told xiaoya old, she won "
Polycystic ovarian cyst, "High blood levels of the male hormone is her hair suddenly developed reasons. Always consider themselves very healthy xiaoya disease struck suddenly feel the fear.

Tags: benign, blood, cancer, cause, cyst, cystic, cysts, early, eat, ert, estrogen, examination, gynecological, knowledge, malignant, mass, ovarian, ovary, physical, polycystic, rate, surface, surgery, symptoms, syndrome, time, treatment, tumor, tumors, usually, women, xiaoya

Recurrent ovarian cancer may reoperation

Health, will be right recurrent ovarian cancer surgery and chemotherapy again whether there has been significant controversy. Fourth Military Medical University Xijing Hospital director of obstetrics and gynecology professor Detang, has nearly 10 years of the 38 treated patients with recurrent epithelial ovarian cancer clinical data were analyzed retrospectively after that, again recurrent ovarian cancer surgery and chemotherapy, can further improve the survival rate of patients.

Tags: cancer, cases, chemotherapy, clinical, early, eat, ovarian, patients, rate, surgery, survival, therapy, treatment, tumor, tumors

Preventive Ovariectomy what age should paragraph

For what age women should be preventive ovariectomy, between different gynecological physician there is a considerable difference. Jacobs Oram and the Royal College of Obstetrics and Gynecology doctors on preventive attitude ovariectomized done a survey, the results showed that: only 2% to gynecologists for women aged 40 to 44 the ovary; 20% of doctors agreed with 45 to 49-year-old women's ovary; 51% think Resectability aged over 49-year-old women's ovary; 85% agree that postmenopausal women with ovarian. Alaska gynecologists, 35% agree with women aged 40 to 44 the ovary; 81% agree with women aged 45 to 49 the ovary; 95% agree with women over the age of 49, the ovary.
Some of the literature suggested that the age for women aged ≥ 40 ovariectomized preventive purposes. However, while some other articles that only deal with ≥ 45 years of age patients with preventive ovariectomy. It is clear that the majority of women with ovarian also not aware of estrogen replacement therapy (estrogen replacement therapy, ERT) the importance, from the reported in the literature it is not difficult to see that the compliance ERT not ideal, however, the role of estrogen loss is real. After ovariectomy, the ERT begin compliance was 31% to 89%; The long-term application, a decrease of 13% to 51%. Under existing ERT compliance of the relevant information can be estimated preventive ovariectomized will lead to the age of 45 or more young women to shorten life expectancy. For example, a 35-year-old women, in preventive ovary after, if they failed to ERT, then her life expectancy will decrease 1.4 years. Siddle, proved to hysterectomy for women, ovarian failure will be the age of natural menopause, as early as four years (45.4? ? .0 49.5-right? ? .04), And 34% of women in the two years after emerging ovarian failure and menopause symptoms .
Thus, clinicians must be aware of ovarian hysterectomy after reservation for women should be ahead of ERT treatment.

Tags: age, early, eat, ert, estrogen, gynecological, head, life, ovarian, ovary, patients, preventive, symptoms, therapy, treatment, women

Ovarian cancer radiotherapy

Most of the malignant ovarian tumors, radiation therapy for various effects are poor. Therefore, in the treatment of malignant ovarian tumor was not first consider radiotherapy. After laparotomy confirmed to be malignant ovarian tumor resection not all, in vitro viable X-ray irradiation. But many of ascites are not OK radiotherapy; The abdominal tumor metastasis to the effect of not limited to those within the pelvic cavity. X-ray irradiation is also used in vitro malignant ovarian tumor before and after surgery. Preoperative radiotherapy for patients with radiation therapy after the word four to six weeks should surgery again night, while radiation caused by adhesions, surgery often caused difficulties. Surgery will be in regular radiation treatment after two weeks before and after the start, such as whole body ill patients should first correct.
(1), abdominal irradiation radiation field including full pots of abdominal viscera, or by Ono divided into two to four vertical irradiation of Ono, tumor dose of 25 Gy ~ / 6 to 8 weeks. General liver, kidney tolerance were 30 Gy and 18 Gy, such as the super-dose, should shielding protection. Whole abdominal irradiation after Ono, the largest general tolerance of 30 Gy / 6 to 7 weeks. This dose is not LD50 of ovarian cancer, while Ono irradiation reaction, difficult patient tolerance. Delcios in 1963, a fully mobile strip abdominal irradiation in the treatment of ovarian cancer. Each abdominal irradiation of 10 cm, radiation field from the upward movement in the entire basin to include abdominal, each irradiation in 12 days. Tumor radiation dose of 26 to 28 Gy. The biological effects of radiation and improve the patient's response to radiotherapy.
(2), pelvic tumor irradiation dose of 40 to 60 Gy, 6 to 8 weeks to complete.
(3), plus whole abdominal pelvic irradiation Ono whole abdominal irradiation may be, or transfer surgery strip irradiation dose with the former. Pelvic organ tolerance, to improve efficacy, and pelvic irradiation dose of 20 to 30 Gy, ovarian cancer is the commonly used method.
(4), abdominal radionuclide therapy for patients early preventive treatment, and only a small residual tumor after treatment. Surgery not cut net of malignant ovarian tumor metastases can be injected with the radioactive colloid 98 or 32 P, or diluted with saline injected into the abdominal cavity to prevent cancer formation of ascites, malignant ovarian cancer has been with ascites, the catheter may produce ascites part, to be injected colloidal gold 98 or 32 P . It should be noted 98 of the radioactive colloid and 32 P for intraperitoneal injection, also caused radioactive hepatitis possible, it should be repeated in application check liver function for timely processing.

Tags: abdominal, body, cancer, cause, days, dose, early, eat, ert, gene, injection, intraperitoneal, irradiation, malignant, metastasis, method, ovarian, patients, pelvic, poor, preventive, radiation, radiotherapy, resection, residual, response, surgery, therapy, time, treatment, tumor, tumors

Ovarian cancer and vascular endothelial growth factor related

Fourth Military Medical University Xijing Hospital maternity doctor completed a Biochemistry and the National Natural Science Foundation-funded projects that vascular endothelial growth factor in epithelial ovarian cancer and the formation of blood vessels play an important role.

Biochemistry and immunohistochemical methods used to detect 37 cases of epithelial ovarian cancer of vascular endothelial growth factor expression showed that ovarian cancer and vascular endothelial growth factor related. Therefore, the use of anti-vascular endothelial growth factor-card issuers ribozyme eukaryotic expression vector, in ovarian cancer-specific antibody-mediated tumor cell block under the vascular endothelial growth factor expression levels of genes in the treatment of ovarian cancer provides a strong basis.

Tags: anti, blood, body, cancer, cases, cell, eat, gene, growth, method, ovarian, treatment, tumor

Ovarian disease that menstrual disorder

Many female menstrual disorder is often encountered problems, including extending or shortening cycle, increased amount of bleeding, these belong to dysfunctional bleeding, referred to as DUB.

Women of childbearing age are generally more because luteal function well, resulting in menstrual disorders, which means although cycle, but the cycle will shorten, or more menstrual bleeding. Some 20 days to the first menstruation, it is because luteal function well. Similarly some may last 30 days, but rather a long time hemorrhage, which is bad because luteal function caused. While these cases more, but the problem is not very serious and <BR>, relatively speaking, not a great amount of bleeding.

Tags: age, bleeding, cancer, cases, cause, cyst, cystic, days, eat, ert, gene, grams, gynecological, increased, ovarian, ovary, polycystic, syndrome, tea, time, treatment, women